iproniazid has been researched along with Degenerative Diseases, Central Nervous System in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gaspar, A | 1 |
| Reis, J | 1 |
| Fonseca, A | 1 |
| Milhazes, N | 1 |
| Viña, D | 1 |
| Uriarte, E | 1 |
| Borges, F | 1 |
| Fantacuzzi, M | 1 |
| Amoroso, R | 1 |
| Carradori, S | 1 |
| De Filippis, B | 1 |
1 review available for iproniazid and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Resveratrol-based compounds and neurodegeneration: Recent insight in multitarget therapy.
Topics: Humans; Neurodegenerative Diseases; Polyphenols; Resveratrol; Stilbenes; Structure-Activity Relation | 2022 |
1 other study available for iproniazid and Degenerative Diseases, Central Nervous System
| Article | Year |
|---|---|
Chromone 3-phenylcarboxamides as potent and selective MAO-B inhibitors.
Topics: Animals; Cell Line; Chromones; Humans; Inhibitory Concentration 50; Models, Molecular; Monoamine Oxi | 2011 |